- Investing.com
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. The company designs and sells scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings and tops, super-soft pima cotton tops, vests, fleeces, and jackets; and necessities comprising scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail stores. FIGS, Inc. was incorporated in 2013 and is headquartered in Santa Monica, California.
Analyst Perspective | With price targets ranging from $5.00 to $9.00, analysts maintain mixed ratings on FIGS as it navigates sector-specific challenges while its market capitalization has nearly doubled to $1.41 billion in 2025. |
Growth Trajectory | Explore FIGS's strategic expansion beyond core scrubs into complementary healthcare apparel and international markets, despite a cautiously conservative full-year outlook. |
Financial Resilience | Demonstrating remarkable performance with quarterly results exceeding expectations, FIGS has improved gross margins while benefiting from normalized operational expenses. |
Healthcare Niche Leade | FIGS has established a distinctive market position with premium, stylish scrubs for healthcare professionals, leveraging a direct-to-consumer model that drives engagement and sales growth. |

Metrics to compare | FIGS | Sector Sector - Average of metrics from a broad group of related Consumer Cyclicals sector companies | Relationship RelationshipFIGSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 107.0x | −4.6x | 11.2x | |
PEG Ratio | 1.18 | −0.09 | 0.02 | |
Price / Book | 4.6x | 3.5x | 1.4x | |
Price / LTM Sales | 3.2x | 0.5x | 1.0x | |
Upside (Analyst Target) | −22.4% | 22.7% | 21.7% | |
Fair Value Upside | Unlock | 6.1% | 9.3% | Unlock |